{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:15:29Z","timestamp":1779279329406,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cyto.2026.157166","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:50:28Z","timestamp":1778568628000},"page":"157166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of IL-1\u03b2\u00a0\u2212\u00a0511 and\u00a0+\u00a03954 polymorphisms and their serum levels with breast cancer in Iraqi women"],"prefix":"10.1016","volume":"203","author":[{"given":"Osama B.","family":"Al-Saffar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2026.157166_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-024-00631-8","article-title":"Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the global burden of disease study 2021","volume":"12","author":"Sha","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cyto.2026.157166_bb0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.18295\/2075-0528.2863","article-title":"Breast and ovarian cancers\u2019 incidence trends among Iraqi women during 2012\u20132022 and their relationship to fertility patterns","volume":"25","author":"Al-Asadi","year":"2025","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"10.1016\/j.cyto.2026.157166_bb0015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cytogfr.2006.07.002","article-title":"Cytokines in breast cancer","volume":"17","author":"Nicolini","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2026.157166_bb0020","first-page":"1","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cyto.2026.157166_bb0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cyto.2009.06.005","article-title":"Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals","volume":"47","author":"Martin","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2026.157166_bb0030","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2026.157166_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.0105-2896.2004.00199.x","article-title":"Cytokines in cancer immunity and immunotherapy","volume":"202","author":"Smyth","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2026.157166_bb0040","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.5114\/aoms.2017.68942","article-title":"Five gene variants in nonagenarians, centenarians and average individuals","volume":"13","author":"Kolovou","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.cyto.2026.157166_bb0045","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3390\/cancers12071791","article-title":"Interleukin-1\u03b2 and Cancer","volume":"12","author":"R\u00e9b\u00e9","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cyto.2026.157166_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.mgene.2019.100546","article-title":"Association analysis of interleukin-1 single nucleotide polymorphisms in viral hepatitis of Iraqi patients","volume":"20","author":"Al-Saffar","year":"2019","journal-title":"Meta Gene"},{"key":"10.1016\/j.cyto.2026.157166_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2024.100608","article-title":"The role of IL-1B in breast cancer bone metastasis","volume":"46","author":"Zhou","year":"2024","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.cyto.2026.157166_bb0060","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41556-018-0173-5","article-title":"IL-1\u03b2 inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization","volume":"20","author":"Casta\u00f1o","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cyto.2026.157166_bb0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.46542\/pe.2024.243.3238","article-title":"The role of IL-1, IL-6 and TNF-\u03b1 in breast cancer development and progression","volume":"24","author":"Al-Qubati","year":"2024","journal-title":"Pharm. Educ."},{"key":"10.1016\/j.cyto.2026.157166_bb0070","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211060144","article-title":"Role of IL-1\u03b2 rs1143634 (+3954C>T) polymorphism in cancer risk: an updated meta-analysis and trial sequential analysis","volume":"49","author":"Jafrin","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.cyto.2026.157166_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1086163","article-title":"Exploring immune interactions in triple negative breast cancer: IL-1\u03b2 inhibition and its therapeutic potential","volume":"14","author":"Wilson","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.cyto.2026.157166_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.804","article-title":"The association between interleukin-1 polymorphisms and their protein expression in Chinese Han patients with breast cancer","volume":"7","author":"Wang","year":"2019","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.cyto.2026.157166_bb0085","series-title":"Determination of IL-2 serum levels with susceptibility to hbv, hcv in some iraqi patients","first-page":"69","volume":"9","author":"Al-Saffar","year":"2018"},{"key":"10.1016\/j.cyto.2026.157166_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.genrep.2024.101934","article-title":"SNPs variety of transforming-growth factor-beta 1 (codon 10 and codon 25) genes are related to viral hepatitis (B type and C type) disease in some Iraqi individuals","volume":"36","author":"Al-Saffar","year":"2024","journal-title":"Gene Reports"},{"key":"10.1016\/j.cyto.2026.157166_bb0095","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211060144","article-title":"Role of IL-1\u03b2 rs1143634 (+3954C>T) polymorphism in cancer risk: an updated meta-analysis and trial sequential analysis","volume":"49","author":"Jafrin","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.cyto.2026.157166_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.genrep.2022.101539","article-title":"Link of IL-1\u03b2 rs16944 polymorphism with breast, cervical and ovarian cancer: a systematic review and meta-analysis","volume":"26","author":"Nahar","year":"2022","journal-title":"Gene Reports"},{"key":"10.1016\/j.cyto.2026.157166_bb0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cyto.2026.157166_bb0110","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.2024.5535","article-title":"Screening for breast cancer","volume":"331","author":"U.P.S.T. Force","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2026.157166_bb0115","first-page":"E36905","article-title":"Breast cancer: a review of risk factors and diagnosis","volume":"103","author":"Obeagu","year":"2024","journal-title":"Med. (United States)"},{"key":"10.1016\/j.cyto.2026.157166_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2024.100608","article-title":"The role of IL-1B in breast cancer bone metastasis","volume":"46","author":"Zhou","year":"2024","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.cyto.2026.157166_bb0125","doi-asserted-by":"crossref","first-page":"R421","DOI":"10.1530\/ERC-17-0309","article-title":"The role of IL-1B in breast cancer bone metastasis","volume":"25","author":"Tulotta","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.cyto.2026.157166_bb0130","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.ejhg.5201410","article-title":"Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power","volume":"13","author":"Salanti","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.cyto.2026.157166_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156659","article-title":"Association of IL-1\u03b2 gene polymorphisms rs1143627, rs1799916, and rs16944 with altered risk of triple-negative breast cancer","volume":"180","author":"Sghaier","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2026.157166_bb0140","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10549-020-05561-1","article-title":"Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990-2017","volume":"180","author":"Chen","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cyto.2026.157166_bb0145","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.3390\/cells11101673","article-title":"Interleukin-1 and nuclear factor kappa B Signaling promote breast Cancer progression and treatment resistance","volume":"11","author":"Diep","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cyto.2026.157166_bb0155","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.7150\/ijms.43981","article-title":"Interleukin-1\u03b2 promotes ox-LDL uptake by human glomerular mesangial cells via LOX-1","volume":"17","author":"Liu","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.cyto.2026.157166_bb0160","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cyto.2026.157166_bb0165","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/429864","article-title":"A note on exact tests of hardy-Weinberg equilibrium","volume":"76","author":"Wigginton","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cyto.2026.157166_bb0170","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ng1847","article-title":"Principal components analysis corrects for stratification in genome-wide association studies","volume":"38","author":"Price","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cyto.2026.157166_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-6-188","article-title":"Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review","volume":"6","author":"Balasubramanian","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cyto.2026.157166_bb0180","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/mutage\/ger025","article-title":"Interleukin 1 beta (IL-1\u03b2) promoter polymorphism and cancer risk: evidence from 47 published studies","volume":"26","author":"He","year":"2011","journal-title":"Mutagenesis"},{"key":"10.1016\/j.cyto.2026.157166_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/aoms\/99839","article-title":"The association between interleukin-1\u03b2 gene polymorphisms and the risk of breast cancer: a systematic review and meta-analysis","volume":"18","author":"Wang","year":"2022","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.cyto.2026.157166_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-662","article-title":"Risk of breast cancer and family history of other cancers in first-degree relatives in Chinese women: a case control study","volume":"14","author":"Zhou","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cyto.2026.157166_bb0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-014-2905-y","article-title":"Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies","volume":"145","author":"Trentham-Dietz","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cyto.2026.157166_bb0200","first-page":"1","article-title":"A case-control study on risk factors of breast cancer among women attending a tertiary care hospital in Kolkata, India","volume":"7","author":"Chakraborty","year":"2020","journal-title":"Cell Biology and Cell Metabolism"},{"key":"10.1016\/j.cyto.2026.157166_bb0205","article-title":"Analysis of the odds ratio for developing breast cancer in women","volume":"82","author":"Pi\u0119ta","year":"2011","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.cyto.2026.157166_bb0210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.SLA.0000059969.64262.87","article-title":"Rating the risk factors for breast Cancer","volume":"237","author":"Singletary","year":"2003","journal-title":"Ann. Surg."},{"key":"10.1016\/j.cyto.2026.157166_bb0215","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/cncr.32815","article-title":"Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history","volume":"126","author":"Mukama","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.cyto.2026.157166_bb0220","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1742-7843.2007.00065.x","article-title":"Serum cytokine levels of interleukin-1\u03b2, \u22126, \u22128, tumour necrosis factor-\u03b1 and vascular endothelial growth factor in breast Cancer patients treated with tamoxifen and supplemented with co-enzyme Q10, riboflavin and niacin","volume":"100","author":"Premkumar","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.cyto.2026.157166_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-6-188","article-title":"Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review","volume":"6","author":"Balasubramanian","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cyto.2026.157166_bb0230","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10549-005-9079-6","article-title":"Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women","volume":"96","author":"Lee","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cyto.2026.157166_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.genrep.2022.101539","article-title":"Link of IL-1\u03b2 rs16944 polymorphism with breast, cervical and ovarian cancer: a systematic review and meta-analysis","volume":"26","author":"Nahar","year":"2022","journal-title":"Gene Reports"},{"key":"10.1016\/j.cyto.2026.157166_bb0240","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1158\/1078-0432.CCR-05-0001","article-title":"Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women","volume":"11","author":"Hefler","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cyto.2026.157166_bb0245","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/jjco\/hyf081","article-title":"Significant reduction in breast cancer risk for Japanese women with interleukin 1B -31 CT\/TT relative to CC genotype","volume":"32","author":"Ito","year":"2002","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.cyto.2026.157166_bb0250","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10549-010-0910-3","article-title":"Three polymorphisms in interleukin-1\u03b2 gene and risk for breast cancer: a meta-analysis","volume":"124","author":"Liu","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cyto.2026.157166_bb0255","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/carcin\/bgu078","article-title":"Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the breast Cancer health disparities study","volume":"35","author":"Slattery","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cyto.2026.157166_bb0260","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","article-title":"Breast cancer\u2014epidemiology, risk factors, and genetics","volume":"321","author":"McPherson","year":"2000","journal-title":"BMJ Br. Med. J."},{"key":"10.1016\/j.cyto.2026.157166_bb0265","doi-asserted-by":"crossref","first-page":"61","DOI":"10.36320\/ajb\/v16.i2.15057","article-title":"Polymorphism of interleukin 1 be polymorphism of interleukin 1 beta C31T in blood and tissue patients with breast tumors: polymorphism of interleukin 1 beta C31T in blood and tissue patients with breast tumors","volume":"16","author":"Hathal","year":"2024","journal-title":"Al-Kufa Univ. J. Biol."},{"key":"10.1016\/j.cyto.2026.157166_bb0270","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/carcin\/bgp122","article-title":"A specific interleukin-1B haplotype correlates with high levels of IL-1\u03b2 mRNA in the lung and increased risk of non-small cell lung cancer","volume":"30","author":"Landvik","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cyto.2026.157166_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep41920","article-title":"IL1B-CGTC haplotype is associated with colorectal cancer in admixed individuals with increased African ancestry","volume":"7","author":"Sanabria-Salas","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2026.157166_bb0280","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3390\/genes15121528","article-title":"Association of variants in IL-1RN (rs2234663) and IL-1\u03b2 (rs1143627, rs16944) and Interleukin-1\u03b2 levels with colorectal cancer: experimental study and in silico analysis","volume":"15","author":"Gallegos-Arreola","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.cyto.2026.157166_bb0285","series-title":"Role of IL-1 gene polymorphisms in common solid cancers, Multifaceted Role IL-1 Cancer Inflamm.","first-page":"1","author":"Singh","year":"2023"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662600061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662600061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:58:14Z","timestamp":1779278294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346662600061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":56,"alternative-id":["S104346662600061X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157166","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of IL-1\u03b2\u00a0\u2212\u00a0511 and\u00a0+\u00a03954 polymorphisms and their serum levels with breast cancer in Iraqi women","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157166"}}